Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis
Clinical trial NCT01863888 · COMPLETED
Trial details
- NCT number
- NCT01863888
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-01-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.